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surfaces and noncritical patient care items play an important role in the transmission of several key health
care−associated pathogens including methicillin-resistant Staphylococcus aureus, vancomycin-resistant
enterococci, Acinetobacter, norovirus, and Clostridium difficile. Thus, surface disinfection of noncritical envi-
ronmental surfaces and medical devices is one of the infection prevention strategies to prevent pathogen
transmission. This article will discuss a bundle approach to facilitate effective surface cleaning and disinfec-
tion in health care facilities. A bundle is a set of evidence-based practices, generally 3-5, that when performed
collectively and reliably have been proven to improve patient outcomes. This bundle has 5 components and
the science associated with each component will be addressed. These components are: creating evidence-
based policies and procedures; selection of appropriate cleaning and disinfecting products; educating staff to
include environmental services, patient equipment, and nursing; monitoring compliance (eg, thoroughness
of cleaning, product use) with feedback (ie, just in time coaching); and implementing a “no touch” room
decontamination technology and to ensure compliance for patients on contact and enteric precautions. This
article will also discuss new technologies (eg, continuous room decontamination technology) that may
enhance our infection prevention strategies in the future.Disinfection
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I and on an advisory board forOver the past decade, there is excellent evidence in the
scientific literature that contaminated environmental surfaces and
noncritical patient care items play an important role in the trans-
mission of several key health care−associated pathogens, including
methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-
resistant enterococci (VRE), Acinetobacter, norovirus, and Clostrid-
ium difficile.1−13 All of these pathogens have been demonstrated to
persist in the environment for days (in some cases months),9,13−15
frequently contaminate the environmental surfaces in rooms of
colonized or infected patients,16 transiently colonize the hands of
health care personnel,17,18 can be transmitted by health care per-
sonnel, and cause outbreaks in which environmental transmission
was deemed to play a role. Importantly, a study by Stiefel et al18
demonstrated that contact with the environment was just as likely
to contaminate the hands of health care providers as was directcontact with the patient. Further, admission to a room in that the
previous patient had been colonized or infected with MRSA, VRE,
Acinetobacter, or C difficile, has been shown to be a risk factor
for the newly admitted patient to develop colonization or infec-
tion.19,20 Thus, surface disinfection of noncritical environmental
surfaces and medical devices (defined as those that contact intact
skin) is one of the important infection prevention strategies to
prevent pathogen transmission.
This infection risk from environmental surfaces is not surprising
as multiple studies have demonstrated that environmental surfaces
and objects in rooms are frequently not properly cleaned and these
surfaces may be important in transmission of health care−associated
pathogens.7 Further, although interventions aimed at improving
cleaning thoroughness have demonstrated the effectiveness of sur-
face disinfection in reducing microbial contamination and/or health
care−associated infections (HAIs),10,11,21−27 many surfaces remain
inadequately cleaned and, therefore, potentially contaminated. The
purpose of this article is to review and update studies on surface dis-
infection1,28,29 and use a best practices bundle created by Havill30 to
facilitate effective surface cleaning and disinfection on noncritical
items in health care facilities.
Noncritical Items
Noncritical items are those that come in contact with intact skin
but not mucous membranes. Intact skin acts as an effective barrier to
most microorganisms; therefore, the sterility of items in contact with
intact skin is “not critical.” Examples of noncritical items are bedpans,
blood pressure cuffs, crutches, bed rails, bedside tables, patient furni-
ture, toys,31 portable equipment (eg, wheel chairs, infusion pumps,
pulse oximeters, blood pressure cuffs, medication carts),8,32,33 and
floors.34,35 The 5 most commonly touched noncritical items in the
patient environment have been quantitatively shown to be bed rails,
bed surface, supply cart, overbed table, and intravenous (IV) pumps.36
In contrast to critical and some semicritical items, most noncritical
reusable items may be decontaminated in which they are used and
do not need to be transported to a central processing area. There is
virtually no documented risk of transmitting infectious agents to
patients via noncritical items37 when they are used as noncritical
items and do not contact nonintact skin, mucous membranes, and/or
sterile tissue. However, these noncritical environmental surfaces (eg,
bedside tables, bed rails) could potentially contribute to secondary
transmission by contaminating hands of health care providers or by
contact with medical equipment that will subsequently come in con-
tact with patients.2
Many Environmental Protection Agency (EPA)-registered liquid
disinfectants have a 10-minute label claim. However, multiple inves-
tigators have demonstrated the effectiveness of these disinfectants
against vegetative bacteria (eg, Listeria, Escherichia coli, Salmonella,
VRE, MRSA), yeasts (eg, Candida), mycobacteria (eg, Mycobacterium
tuberculosis), and viruses (eg, poliovirus) at exposure times of 30-60
seconds.38−44 Thus, it is acceptable from a microbial inactivation per-
spective to disinfect noncritical medical equipment (eg, blood pres-
sure cuff) and noncritical surfaces (eg, bedside table) with an EPA-
registered disinfectant or disinfectant/detergent at the proper use-
dilution and a contact time of ≥1 minute.29,41,43−45 Considering that
the typical drying time for a liquid disinfectant on a surface is 1-4
minutes,44 1 application of the germicide on all hand contact or
touchable surfaces to be disinfected is recommended.Current Topics (Mops, Wipes, Floors, Quat Absorption to Wipes, Biofilms,
and Disinfectant Kill Time)Mops and Wipes
Mops (microfiber and cotton-string), reusable cleaning cloths, dis-
posable wipes, and sprays are regularly used to achieve low-level dis-
infection.28 Disinfectant cleaning wipes and sprays (eg, quaternary
ammonium compounds [Quats] and alcohol, chlorine) have been
found to be highly effective (>4-log10 reduction) in removing/inacti-
vating epidemiologically important pathogens.46−48 Hospital laun-
dering practices may not be sufficient to remove microbial
contaminants of reusable cleaning towels.49,50
Mops (especially cotton-string mops) are commonly not kept ade-
quately cleaned and disinfected, and if the water-disinfectant mixture
is not changed regularly (eg, after every 3-4 rooms, no longer than
60 minute intervals), the mopping procedure may actually spread
heavy microbial contamination throughout the health care facility.51
In 1 study, standard laundering provided acceptable decontamination
of heavily contaminated mopheads but chemical disinfection with a
phenolic was less effective.51 The frequent laundering of cotton-
string mops (eg, daily) is, therefore, recommended. Microfiber mops
have demonstrated superior microbial removal compared to cotton
string mops when used with detergent cleaner (ie, 95% vs 68%,
respectively). Use of a disinfectant did significantly improve microbial
removal when a cotton string mop was used when compared to the
detergent cleaner (ie, 95% vs 68%, respectively).52Quat Absorption to Wipes
Several studies have demonstrated that the decreased activity of
quaternary ammonium compounds via binding when exposed to cot-
ton wipes, microfiber, and 1 of 2 disposable wipes.53−55 These evalua-
tions demonstrated a significant reduction (>50%) of quaternary
ammonium compounds concentrations after exposure to the wipes/
towels.53−55 One study tested the disinfectant performance using a
standardized test and the disinfectants passed when exposed to the
microfiber towels and failed when exposed to the cotton towels.53
Although cotton and microfiber retain the quaternary ammonium
compound, 1 unpublished study has shown they provide equivalent
removal/inactivation of MRSA from a surface as nonwoven spunlace
wipes (eg, 4.41-log10 reduction with cotton and Quat, 4.60-log10
reduction with spunlace, 4.51-log10 reduction with microfiber, 4.40-
log10 reduction with cellulose; Rutala, Gergen, Weber, unpublished
results, 2013). The nonwoven spunlace wiper was prepared with a
fiber content intended not to bind Quats.55 Manufacturers of dispos-
able wipes believe they have addressed this issue as any absorption
of the Quat that may occur has been taken into account because the
wipes are tested via EPA-registration tests for active ingredient con-
tent from the expressed liquid. Additional investigations are neces-
sary to ensure a minimum effective concentration is present to
achieve the antimicrobial label claim.
Floors
Studies have recently evaluated hospital floors as a potential
source of pathogen dissemination. Deshpande et al34 found floors in
patient rooms were frequently contaminated with health care patho-
gens (eg, C difficile, MRSA, VRE [contamination range was 35%-53%
during the patient stay]), and high-touch objects (eg, blood pressure
cuffs and call buttons) were often (41%) in contact with the floor. Con-
tact with objects on the floors resulted in transfer of pathogens to
hands or gloves at varying frequencies (eg, C difficile 3%, VRE 6%, and
MRSA 18%).34 Another study found that a nonpathogenic virus inocu-
lated onto floors in hospital rooms disseminated rapidly to the foot-
wear and hands of patients and to high-touch surfaces in the rooms.
The virus was also frequently found on high-touch surfaces in adja-
cent rooms and nursing stations. This suggests that health care pro-
viders contributed to dissemination after acquiring the virus during
contact with surfaces or patients.35 Although further studies are
needed to determine if floors contribute to pathogen transfer, these
data support the disinfection of floors.
Biofilms
Although biofilms are traditionally associated with wet environ-
ments such as indwelling medical devices, some data suggest that
biofilms have also been identified on dry surfaces.56−58 In 1 multicen-
ter study, 61 terminally cleaned items from 3 different United King-
dom hospitals, were investigated using culture-based methods and
scanning electron microscopy. Multispecies dry biofilms were recov-
ered from 95% of 61 samples.58 These dry biofilms were predomi-
nately formed by gram-positive bacteria. Biofilms are less susceptible
to disinfectants but oxidizing agents are more effective.59,60 The role
of dry biofilms in transmission via surfaces needs to be established as
well as what germicidal products are effective against dry biofilms.
Disinfectant Kill Time
Each chemical disinfectant requires a specific length of time it
must remain in contact with a microorganism to achieve complete
inactivation. This is known as the “kill time” (or “contact time") and
the registered kill times for each microorganism will be clearly listed
on the label of EPA-registered liquid disinfectants. Fast kill times are
important because they provide confidence there is complete killing
of the most common health care−associated pathogens before the
disinfecting solution dries or is removed, and before patients or staff
Table 1
Science-based components of a health care policy for cleaning/disinfection of noncriti-
cal environmental services and medical devices
 Standardize cleaning/disinfection of patient rooms and noncritical medical
devices throughout the hospital.
 An EPA-registered hospital disinfectant.
 All touchable, hand contact surfaces should be wiped daily, when spills occur,
and when the surfaces are visible soiled.
 All noncritical medical devices should be disinfected daily and when soiled.
The institutional protocol should include shared portable equipment such as
wheelchairs, ECG machines, portable x-ray machines, glucometers, and blood
pressure cuffs.
 Cleaning should be from the cleanest to the dirtiest areas (the bathroom will be
cleaned last followed by the floor).
 Change cleaning cloths after every room and use at least 3 cloths per room;
typically, 5-7 cloths.
 Damp mop floor with a disinfectant-detergent.
 If disinfectant is prepared on-site: document correct concentration as concentra-
tion delivered by automated disinfectant dispensers vary.54
 Address treatment time/contact time/kill time for wipes and liquid disinfectants
(eg, treatment time for wipes is the kill time and includes a wet time via wiping
as well as the undisturbed time).
 Cleaning/disinfecting staff must be trained on personal protective equipment and
comply with the instruction.
ECG, electrocardiogram; EPA, Environmental Protection Agency.are likely to re-touch the surface. For example, some disinfectants
may have a kill time for vegetative bacteria of 1 minute, which means
that the bacteria listed on its label will be inactivated within 1 min-
ute. Other products, often-concentrated formulas that require dilu-
tion before use, are registered by the EPA for use against bacteria and
viruses (eg, HBV, HIV) with a contact time of 10 minutes. Such a long
contact time is not practical for disinfection of environmental surfa-
ces in a health care setting because most health care facilities only
apply a water-based disinfectant once and allow it to dry, which nor-
mally takes 1-4 minutes.44
Although the Centers for Disease Control and Prevention guide-
line mentions the disinfectant user must follow all applicable label
instructions on EPA-registered products, it discusses many scientific
studies that have demonstrated the efficacy of hospital disinfectants
against pathogens with a contact time of at least 1 minute.43 To our
knowledge, there are only 2 articles in the peer-review literature
that assessed EPA-registered disinfectants that are directly on point
of this issue. One publication tested common health care disinfec-
tants (such as Quat-alcohol, chlorine, phenolic) against S aureus,
E coli, Pseudomonas aeruginosa, and Salmonella choleraesuis at 30
seconds and 5 minutes and showed the maximum log10 reduction
(ie, »5-log10 reduction) was achieved in 30 seconds.41 Thus, this
study showed the log10 reductions at 30 seconds was identical to
the log10 reduction at 5 minutes. West et al44 corroborated this
study and demonstrated that wet time is not crucial for disinfection
as log10 reductions at 30 seconds were not significantly different
than the log10 reductions at 60 minutes (ie, »4-log10 reduction at
both time points, 30 seconds and 60 minutes). Because the log10
reductions at 30 seconds and 60 minutes were nearly identical,
there was no microbial reduction benefit for wet times >30 sec-
onds.44 This refutes the proposition that visual wetness is a proxy
for determining effective disinfection61 and challenges the need for
citations and punitive actions by accrediting agencies when a disin-
fectant does not stay wet for its registered contact time (eg, dries in
1 minute but registered contact time is 2 minutes). Clearly, wet
times are important but there are no data that demonstrate that
wet times beyond 1 minute improve microbial reduction and have
an infection prevention benefit. The disinfectant should be applied
wet enough to achieve sufficient wetness to ensure that a wet time
of at least 1 minute is achieved. When the wipe is too dry to achieve
the 1 minute wet time it should be replaced with a fresh wet wipe.
At University of North Carolina Hospitals, we developed risk assess-
ments, which justifies the use of hospital disinfectants and disinfec-
tant wipes (eg, Quat-alcohol) with a wet time of 1 minute.62 This 1
minute wet time for noncritical environmental surfaces and non-
critical medical devices is consistent with the review of the litera-
ture in the Centers for Disease Control and Prevention guideline as
well as 2 studies directly on point to this issue.41,44
A Bundle Approach
The Institute for Healthcare Improvement developed the concept
of bundles to assist health care providers to more reliably provide
the best care for patients. A bundle is a set of evidence-based practi-
ces, generally 3-5, that when performed collectively and reliably
have been proven to improve patient outcomes. The “power” of a
bundle comes from a body of science that supports it and execution
of the components of the bundle with complete consistency. The sci-
ence in the bundle are not new and are generally well established
but they are not performed unfailingly. As stated by Dr. Carol Hara-
den63 of the Institute for Healthcare Improvement, a bundle ties the
science-based interventions together into a package that providers
know must be followed uniformly and completely for maximal
patient benefit.
This bundle, identified by Havill30, has 5 components, which are
creating policies and procedures; appropriate selection of cleaningand disinfecting products; educating staff to include environmental
services (ES), patient equipment and nursing; monitoring compliance
(eg, thoroughness of cleaning, product use) with feedback; and
implement a “no touch” room decontamination technology and
ensure compliance for patients on contact and enteric precautions.
This article will briefly review these practices.Creating Policies and Procedures
Environmental cleaning and disinfection are an integral part of
preventing transmission of pathogens. Some science-based practices
of a health care policy for cleaning and disinfection of noncritical ES
and medical devices are defined in Table 1. One component of policy
development is the standardization of cleaning/disinfecting of patient
rooms and equipment throughout the hospital to ensure all surfaces
are being cleaned and disinfected per institutional policy. At Univer-
sity of North Carolina Hospitals, the infection prevention staff found:
some units using ES to clean and disinfect certain pieces of equipment
(eg, Dinamap blood pressure monitor, IV pumps/poles, sequential
compression device [SCD] pumps); some units used patient equip-
ment; and some units used nursing staff (written communication, K.
Schultz, 2017). This results in many problems to include ES staff must
remember what their duties are in different patient care areas. This is
especially true in which nurses or ES staff float to various care units
such as during second and third shift. This was resolved through a
multidisciplinary group that created a standardized plan for cleaning
patient rooms and pieces of patient equipment through the hospital.
The group decided the ES staff were responsible for cleaning and
disinfecting Dinamaps, IV poles/pumps, and SCD pumps, whereas
nursing staff were responsible for clearing out all linens, telemetry
box with wires, and remove disposable items (eg, SCD sleeves, O2
probes, blood pressure cuffs) within 15 minutes of patient discharge.
Normal nursing devices such as halter monitors, blood glucose
meters, and portable pulse oximeters were assigned to the unit nurs-
ing staff to clean and disinfect (written communication, K. Schultz,
2019). Institutional policy must ensure all patient care equipment
and surfaces are receiving appropriate cleaning and disinfection by
assigning these responsibilities,64 ensuring adequate time to perform
the service and auditing compliance.
Table 2
Properties of an ideal disinfectant
1. Broad spectrum: should have a wide antimicrobial spectrum, including kill
claims for the pathogens that are the common causes of HAIs and outbreaks.
2. Fast acting: should have a rapid kill and short kill/contact time listed on the
label.
3. Remains wet: should keep surfaces wet long enough to meet listed kill/treat-
ment time for wipes/sprays with a single application or meet wet-times rec-
ommended by evidence-based guidelines.
4. Not affected by environmental factors: should be active in the presence of
organic matter (eg, blood, sputum, feces) and compatible with soaps, deter-
gents, and other chemicals encountered in use.
5. Nontoxic: should not be irritating to the user, visitors, and patients. It should
not induce allergic symptoms (especially asthma and dermatitis). The toxicity
ratings for disinfectants are danger, warning, caution, and none.
6. Surface compatibility: should be proven compatible with common health care
surfaces and equipment.
7. Persistence: should have sustained antimicrobial activity or residual antimicro-
bial effect on the treated surface.
8. Easy to use: should be available in multiple forms such as wipes (large and
small), sprays, pull-tops, refills; directions for use should be simple and contain
information about personal protective equipment as required.
9. Acceptable odor: should have an odor deemed acceptable by users and
patients.
10. Economical: costs should not be prohibitively high but when considering costs
of disinfectant should also consider product capabilities, cost per compliant
use, etc.
11. Solubility: should be soluble in water.
12. Stability: should be stable in concentrate and use dilution.
13. Cleaner: should have good cleaning properties.
14. Nonflammable: should have flash point below 150°F.
Modified from Molinari et al65 and Rutala andWeber29
HAIs, health care−associated infections.Selecting Cleaning and Disinfecting Products
The 2 essential components for effective surface disinfections are
the product and the practice. The perfect disinfectant, or product, for
health care disinfection has not been introduced; however, there is a
wide array of excellent disinfectants that offer a range of characteris-
tics. Table 2 examines the properties of the ideal disinfectant and
Table 3 reviews the advantages and disadvantages of the low-level
disinfectants used for surface disinfection in health care facilities.29
The disinfectants used in health care facilities are 1-step products,
that is, they clean and disinfectant in 1-step rather than requiring
2 independent steps (ie, cleaning, followed by disinfection).29 In gen-
eral, no precleaning is necessary unless spill or gross contamination
is present in which case cleaning precedes the use of a disinfectant.
Disinfectants are intended for use on hard, nonporous surfaces; how-
ever, some products are EPA-registered for application to soft surfa-
ces such as hospital privacy curtains.69 Hospitals should avoid the use
of noncleanable surfaces such as fabric chairs in clinical areas and use
a cleanable covering fabric (eg, vinyl). Organic matter interferes with
the effectiveness of the disinfectant by altering the antimicrobial
activity of the disinfectant or protecting the pathogen from exposure
to the disinfectant. Device material (eg, polypropylene and ultra-high
molecular weight polyurethane), cleaning agents, surface roughness,
and the presence of blood test soil and bacteria all interact and affect
the cleanability of reusable medical devices.48 In this article, we use
the term “cleaning/disinfection” to reference this 1-step process for
cleaning and disinfecting a noncritical item.29 “Cleaning” refers to the
removal of surface debris (eg, dust, organic material), whereas “disin-
fection” refers to the use of a disinfectant or germicide designed to
kill microorganisms. Cleaning/disinfection or environmental cleaning,
which refers broadly to an organized process for cleaning, disinfect-
ing, and monitoring,7,70 is a horizontal control measure. Horizontal
controls are broad-based approaches to infection prevention as they
attempt reduction to all infections owing to all pathogens and includehand hygiene, environmental control, and minimizing unnecessary
use of invasive devices.71 Often cleaning is enhanced by detergents
and surfactants. Surfactants enhance the cleaning efficacy of the dis-
infectant and ensure complete and even coverage of the surface, pre-
venting beading that occurs with some liquids.29,72 It is important to
achieve even and thorough coverage of a surface to result in even and
complete disinfection. Multiple studies have shown 10%-50% of the
surfaces in patient rooms colonized or infected with C difficile, MRSA
and VRE are contaminated with these pathogens and a lack of thor-
oughness of cleaning contaminated surfaces in patient rooms (mean
32% of objects cleaned) has been linked to an overall 120% increase
risk of infection to the next occupant in that room.5,19,73
Although the process of selecting an optimal health care product
or disinfectant used for low-level disinfection of noncritical items is
commonplace in health care facilities, there are limited articles in the
peer-reviewed literature on this topic.29 Studies support the use of
disinfection rather than the use of a nongermicidal detergent on envi-
ronmental surfaces in health care.10,74 One study showed that daily
use of a disinfectant applied to environmental surfaces with a 80%
compliance is superior to a nongermicidal detergent because it
results in significantly reduced rates of HAIs caused by C difficile,
MRSA and VRE.75 Nongermicidal detergents are not recommended
for multiple reasons,74 to include detergent wipes transfer signifi-
cant amounts of epidemiologically important pathogens (eg, MRSA,
C difficile) over surfaces76 and disinfectants are more effective than
detergents in reducing microbial contamination.47 Similarly, results
have demonstrated efficient transfer of C difficile spores from con-
taminated-to-clean surfaces by nonsporicidal wipes and overused
sporicidal wipes.77
Educate Staff on Surface Disinfection Policies and Practices
The other component of effective surface disinfection is the prac-
tice of thorough application such that the disinfectant contacts all
hand-contact or touchable surfaces. It involves proper training of hos-
pital staff (especially ES and nursing) and adherence to the manufac-
turer’s label instructions (except in the cases in which an institution
may prepare a formal risk assessment to follow alternate contact
times such as a ≥1 minute wet time).62 Several investigators have
shown that educational interventions directed at ES, enhanced clean-
ing, and additional staff can result in improved decontamination of
environmental surfaces.10,11,21−27 Other factors that affect practice
and performance include: sufficient cleaning time; contact time; con-
centration; surface type; frequency of changing wipes; organic soil
and hard water; and porosity of the surface. The combination of prod-
uct and practice results in effective surface disinfection, including the
reduction of patient risk via microbial removal and/or inactivation
and improved patient outcomes.10,11,21−27,29 The criticality of practice
is highlighted by studies that demonstrate surface contamination
with epidemiologically important pathogens is owing to a failure to
thoroughly clean and disinfect surfaces rather than a faulty product
or procedure.78
A curriculum should be developed for the training and education
of cleaning and disinfecting personnel in health care facilities. This
training should be provided at employment and on a regular basis
(eg, daily huddles, weekly/monthly in-service training). The training
should include: what items must be cleaned (eg, all hand contact
items such as side rails, overbed table, television remote control); the
type of cleaning (eg, isolation room, routine daily cleaning, discharge
cleaning); order in which to clean the items (ie, cleanest to dirtiest
[bathroom last followed by the floor]); the dilution of the EPA-regis-
tered disinfectant (if not ready-to-use or disposable wipe); appropri-
ate test strip of the disinfectant if mixed on-site and the results
documented; how many wipes per room; and why ES staff are valu-
able members of the infection prevention team.30,79 Sufficient time
Table 3
Summary of advantages and disadvantages of disinfectants used as low-level disinfectants
Disinfectant active Advantages Disadvantages




 Used to disinfect small surfaces such as rubber stoppers on
medication vials
 No toxic residue
 Not sporicidal
Microbicidal activity affected by organic matter
 Slow acting against nonenveloped viruses (eg, norovirus)
 No detergent or cleaning properties
 Not EPA-registered
 Damage some instruments (eg, harden rubber, deteriorate glue)
 Flammable (large amounts require special storage)
 Evaporates rapidly making contact time compliance difficult
 Not recommended for use on large surfaces
 Outbreaks ascribed to contaminated alcohol66
Sodium hypochlorite
(chlorine)
 Bactericidal, tuberculocidal, fungicidal, virucidal
 Sporicidal (in high concentrations)
 Fast acting
 Inexpensive (in dilutable form)
 Nonflammable
 Unaffected by water hardness
 Reduces biofilms on surfaces
 Relatively stable (eg, 50% reduction in chlorine concentration in
30 d)67
 Used as the disinfectant in water treatment
 EPA-registered
 Reaction hazard with acids and ammonias
 Leaves salt residue
 Corrosive to metals (some ready-to-use products may be formulated
with corrosion inhibitors)
 Unstable active (some ready-to-use products may be formulated with
stabilizers to achieve longer shelf life)
Microbicidal activity affected by organic matter
 Discolors/stains fabrics
 Potential hazard is production of trihalomethane
May cause skin and eye irritation
 Odor (some ready-to-use products may be formulated with odor
inhibitors)




 Bactericidal, tuberculocidal, fungicidal, virucidal
 Fast efficacy
 Easy compliance with wet-treatment times
 Safe for workers (lowest EPA toxicity category, IV)




More expensive than most other disinfecting actives
 Not sporicidal at low concentrations
 Some materials compatibility issues
Iodophors  Bactericidal, mycobactericidal, virucidal
 Nonflammable
 Used for disinfecting blood culture bottles
 Not sporicidal
 Shown to degrade silicone catheters
 Requires prolonged contact to kill fungi
 Stains surfaces
 Used mainly as an antiseptic rather than disinfectant
Phenolics  Bactericidal, tuberculocidal, fungicidal, virucidal





 Absorbed by porous materials and irritate tissue
 Depigmentation of skin caused by certain phenolics








 Bactericidal, fungicidal, virucidal against enveloped viruses
(eg, HIV)




 Persistent antimicrobial activity when undisturbed
 Inexpensive (in dilutable form)
 Not sporicidal
 In general, not tuberculocidal and virucidal against nonenveloped
viruses
 High water hardness and cotton/gauze can make less microbicidal
 A few reports documented asthma as result of exposure to benzalko-
nium chloride
Microbicidal activity affected by organic matter
 Absorption by cotton, some wipes may diminish microbicidal activity




 Bactericidal, tuberculocidal, fungicidal, virucidal (enveloped and many




 Persistent antimicrobial activity when undisturbed
 EPA-registered
 Not sporicidal
 Evaporates more rapidly than water-based disinfectants
Peracetic acid/hydrogen
peroxide
 Bactericidal, fungicidal, virucidal and sporicidal (eg, Clostridium difficile)
 Active in the presence of organic material
 Environmentally friendly by-products (acetic acid, O2, H20)
 EPA-registered
 Surface compatible
 Lack of stability
 Potential for material incompatibility (eg, brass, copper)
More expensive than most other disinfecting actives
 Odor may be irritating
 Can cause mucous membrane and respiratory health effects68
Modified from Rutala and Weber1,29,43
If low-level disinfectant is prepared on-site (not ready-to-use), document correct concentration at a routine frequency as the concentration delivered by automated disinfectant dis-
pensers vary.54
EPA, Environmental Protection Agency; IV, intravenous.must be allowed to perform the job properly or the hospital risks
poor patient outcomes via secondary spread via contaminated envi-
ronmental surfaces and noncritical patient care devices.80 Some
authors have suggested that if you follow the recommended practice
steps, an occupied patient room clean will take 25-30 minutes,
whereas a terminal room clean will take 40-45 minutes.80Improving Room Cleaning and Disinfection
The cleaning/disinfection of noncritical surfaces in hospitals is
essential for reducing microbial contamination and reducing
HAIs.7,10,70 Compliance or enforcing routine environmental cleaning/
disinfecting measures has been associated with reduction of
microbial contamination and/or reduction in HAIs in many stud-
ies.10,11,21−27,81 The Agency for Healthcare Research and Quality
review offers an overview of the monitoring strategies to assess and
improve environmental cleaning/disinfection.7,70 These include:
visual inspection; microbiologic methods; fluorescent markers; and
adenosine triphosphate (ATP) assays. Presently, polymerase chain
reaction-based technology has a limited role for assessing environ-
mental contamination, is investigational, and does not differentiate
between the presence of viable and nonviable microorganisms.70
Investigators have reported that intervention programs aimed at
ES workers resulted in significant improvement in cleaning practi-
ces.82−84 Such interventions have generally included multiple activi-
ties: improved education; monitoring the thoroughness of cleaning
(eg, by use of ATP assays or fluorescent dyes) with feedback of perfor-
mance to the ES workers;84 adequate time; and/or use of cleaning
checklists. A checklist facilitates consistent quality and ensures ES
staff know what they are supposed to do. We have found that assign-
ment of cleaning responsibility (eg, environmental surfaces and non-
critical medical devices such as Dinamaps, IV poles/pumps, and SCD
pumps to be cleaned by ES) is also important to ensure all objects and
surfaces are decontaminated, especially the surfaces of medical
equipment (eg, cardiac monitors). Improved environmental cleaning
has been demonstrated to reduce the environmental contamination
with VRE,78,85 MRSA,85 and C difficile.27 Importantly, no study has
reported in the postintervention period, proper cleaning of >85% of
objects. Further, all studies have only focused improvement on a lim-
ited number of “high risk” objects.19,82 Thus, a concern of published
studies is that they have only demonstrated improved cleaning of a
limited number of “high risk” objects (or “targeted” objects) not an
improvement in the overall thoroughness of room decontamination.
Several studies have shown that educational interventions
directed at ES, enhanced cleaning, and additional staff can result in
improved decontamination of environmental surfaces and/or reduc-
tion of HAIs.10,11,21−27 Adequate staffing, as well as supervision, is
essential to the success of the adherence to evidence-based cleaning/
disinfection practices (Table 1) and for the work to be completed
properly. Increase staffing and modifications of practice (eg, 2-3 times
daily disinfection during norovirus outbreak) may be needed in the
presence of an outbreak.86 There are no guidelines in the United
States regarding the time allotted for cleaning/disinfected patient
rooms in hospitals (ft2/hour).87 In general, the hospital’s practices (eg,
frequency of cleaning) and the disinfectants used are based on the
scientific literature (eg, a sporicidal agent [such as chlorine or perace-
tic acid/hydrogen peroxide (HP)] for C difficile)10 and not based of the
vulnerability of patients (eg, intensive care units)86 as all patients in
US hospitals are considered severely ill and highly susceptible to
infection. Factors that affect staffing include: type of care area (eg,
patient room; showers, toilets and baths; presence of carpet); occu-
pancy factors (eg, frequency of cleaning required); equipment factors
(eg, type of cleaning tools available [mop and bucket vs automated
floor cleaner]); training factors (eg, staff experience); and regulatory
requirements.86 The importance of ES staff in preventing infection
transmission must be recognized by hospital administration. The “C”
suite must appreciate that ES is both a clinical department and an
aesthetic department.80 Clinically, ES staff remove bacteria from sur-
faces that reduce the risk of infection via contaminated surfa-
ces,5,10,11,19,21−27,73 and aesthetically, they provide a hygienically
clean and safe place for the patient to recover.80
Compliance Monitoring and Feedback
Hospital cleanliness continues to attract patient attention, and in
the United States it is still primarily assessed via visual cleanliness
(eg, dust, organic debris) of surfaces, which is not a reliable indicator
of microbial contamination.88,89 ATP bioluminescence measuresorganic debris (each unit has its own reading scale, <250-500 relative
light units-RLU) but is not a reliable indicator of microbial contamina-
tion.70 Fluorescent marking is done with a transparent, easily cleaned,
environmentally stable marking solution that fluoresces when
exposed to an ultraviolet (UV) light. It is applied by the infection pre-
ventionist (IP) or ES manager after the patient is discharged and
unknown to the ES staff. After ES cleaning, the markings are reas-
sessed by the IP or ES manager and the thoroughness of cleaning
monitored and the immediate feedback provided to the person(s)
cleaning/disinfecting the room (eg, 4 of 10 marker surfaces wiped,
40% compliance with thoroughness of cleaning and disinfection).
Microbiologic methods have also been used to evaluate microbial
contamination of surfaces.19 This method can be costly and patho-
genic specific. Although there are no accepted criteria for defining a
surface as “clean” using microbiologic methods, some investigators
have suggested that microbial contamination should be 2.5 colony-
forming units (CFU)/cm2 to <5 CFU/cm2.83,90 Studies have shown that
this level of contamination may be easily achievable as the microbial
burden of room surfaces in 1 hospital went from 57 CFU/Rodac
(2.3 CFU/cm2) to 8 CFU/Rodac (0.3 CFU/cm2) prior to and after
cleaning.91 Based on surface cleaning and disinfection practices that
are used in the United States, a revised stricter pass benchmark for
microbial contamination may need to be considered (<1 CFU/cm2).
Studies have demonstrated suboptimal cleaning by aerobic colony
counts as well as the use of the ATP bioluminescence and fluorescent
markers.19,89,92,93 For example, Carling et al82 assessed the thorough-
ness of terminal cleaning in the patient’s immediate environment in
23 acute care hospitals (1,119 patient rooms) by using a transparent,
stable solution that fluoresces when exposed to handheld UV light.
The overall thoroughness of cleaning, expressed as a percent of surfa-
ces evaluated, was 49% (range for all hospitals, 35%-81%). A study
using ATP bioluminescence assays and aerobic cultures demonstrated
that medical equipment frequently had not been disinfected as per
protocol.33
ATP bioluminescence and fluorescent markers are preferred to
aerobic plate counts because they provide an immediate assessment
of cleaning effectiveness. Two recent reviews reported ATP as a quick
and objective monitoring method; however, it was poorly standard-
ized with low specificity and sensitivity in detecting bacteria.70,94,95
In a comparison study of the 4 methods to assess cleaning, we found
that the fluorescent marker was the most useful tool in determining
how thoroughly a surface was wiped as it mimicked the microbiolog-
ical data better than ATP. For example, compared with microbiolog-
ical data (using benchmark of 2.5 CFU/cm2 x 25 cm2/Rodac = 62.5
CFU/Rodac), 72% were classified as clean with fluorescent markers,
compared to 27% were classified as clean compared to ATP. There
was no statistical correlation between ATP levels and standard aero-
bic plate counts.96
A novel approach to improving the thoroughness of cleaning has
been introduced and involves a color additive to the disinfectants (eg,
bleach) that improves visualization of surface coverage and contact
time to improve thoroughness of cleaning.97−99 The color additive for
bleach disinfection wipes may reduce the corrosive damage of stain-
less steel.100 Studies should be done to demonstrate if use of a color-
ized disinfectant improves the thoroughness of cleaning/disinfection,
reduces microbial contamination, and reduces HAIs.
“No Touch” (or Mechanical) Methods for Room Decontamination
As noted earlier, multiple studies have demonstrated that environ-
mental surfaces and objects in rooms are frequently not properly
cleaned and these surfaces may be important in transmission of health
care−associated pathogens. Further, interventions aimed at improving
cleaning thoroughness have demonstrated effectiveness in reducing
microbial contamination on surfaces and/or HAIs 10,11,21−27 as well as
studies involving disinfectant product substitutions (eg, Quat to chlo-
rine for C difficile) and studies involving “no touch” room decontamina-
tion technologies.3,10,101 Nonetheless, many surfaces remain
inadequately cleaned, and therefore potentially contaminated, and put
the next patient at risk for the previous patient’s pathogen. For this
reason, several manufacturers have developed room disinfection units
that can effectively decontaminate environmental surfaces and objects
and/or inoculated test surfaces.3,102−135 The 2 systems that have been
studied comprehensively and will be discussed are UV light and HP
systems.126 These technologies supplement, but do not replace, stan-
dard cleaning and disinfection because surfaces must be physically
cleaned of dirt and debris.
UV Light for Room Decontamination
UV irradiation has been used for the control of pathogenic micro-
organisms in a variety of applications, such as control of Legionellosis,
as well as disinfection of air, surfaces, and instruments.136,137 At cer-
tain wavelengths, UV light will break the molecular bonds in DNA,
thereby destroying the organism. UV-C has a characteristic wave-
length of 200-270 nm (eg, 254 nm), which lies in the germicidal
active portion of the electromagnetic spectrum of 200-320 nm.
Another UV device uses pulsed-xenon radiation, which produces UV
light in the 200-320 nm range. The efficacy of UV irradiation is a func-
tion of many different parameters such as organic load, distance from
the UV device, pathogen, dose, exposure time, lamp placement, direct
or indirect line of sight from the device, room size and shape, inten-
sity, reflection, and air movement patterns. Studies have systemati-
cally investigated how these parameters affect the effectiveness of
UV126,138−140 as well as logistic and administrative challenges (eg,
room identification, time pressures from bed control).141
Weber et al126 summarized multiple studies that assessed the
effectiveness of UV devices to inactivate microbes inoculated onto
test surfaces that are then placed in a typical room. The most com-
monly tested organisms were epidemiologically important health
care−associated pathogens and included MRSA, VRE, C difficile, and
Acinetobacter spp. In general, the studies showed >3-log10 vegetative
bacteria can be killed on carriers in 5-25 minutes by UV-C, and UV-C
requires greater time and energy to kill a spore-forming organisms
such as C difficile spores.102−110
HP Systems for Room Decontamination
Several systems that produce HP (eg, HP vapor, aerosolized dry
mist HP) have been studied for their ability to decontaminate envi-
ronmental surfaces, objects in hospital rooms, and unused medical
supplies.142 HP vapor has been used increasingly for the decontami-
nation of rooms in health care.107,111−120,134 These investigators
found that HP systems are a highly effective method for eradicating
various pathogens (eg, MRSA, M tuberculosis, Serratia, C difficile
spores, Clostridium botulinum spores) from inoculated carriers, rooms,
furniture and equipment.
Comparison of UV Irradiation versus HP for Room Decontamination
The UV-C device studied and the systems that use HP have their
own advantages and disadvantages143 and there is now ample evi-
dence that these “no-touch” systems can reduce environmental con-
tamination with health care−associated pathogens. However, each
specific system should be studied, and its efficacy demonstrated before
being introduced into health care facilities. The main advantage of
both units is their ability to achieve substantial reductions in vegeta-
tive bacteria and reduce HAIs. As noted earlier, manual cleaning has
been demonstrated to be suboptimal as many environmental surfaces
are not cleaned. Another advantage is their ability to substantiallyreduce C difficile as low-level disinfectants (such as quaternary ammo-
nium compounds) have only limited or no measurable activity against
spore-forming bacteria.143 Both systems are residual free and they
decontaminate all exposed surfaces and equipment in the room.
The major disadvantages of both decontamination systems are the
substantial capital equipment costs, the need to remove personnel
and patients from the room, thus limiting their use to terminal room
disinfection (must prevent/minimize exposure to UV and HP), the
staff time needed to transport the system to rooms to be decontami-
nated and monitor its use, the need to physically clean the room of
dust and debris, and the sensitivity to use parameters. There are sev-
eral important differences between the 2 systems. The UV-C system
offers faster decontamination that reduces the “down” time of the
room before another patient can be admitted. The HP systems have
been demonstrated to be more effective in eliminating spore-forming
organisms.134,135 Whether this improved sporicidal activity is clini-
cally important is unclear as studies have demonstrated that although
environmental contamination is common in the rooms of patients
with C difficile infection, the level of contamination of C difficile is rela-
tively low (eg, level of C difficile surface contamination below 1-log10
[<10 CFU per Rodac or 25cm2]), which is also true for MRSA and VRE.
In the past 10 years, multiple trials have assessed the efficacy of
UV and HP room decontamination units for reducing HAIs. There are
at least 6 clinical trials that demonstrate a reduction of HAIs with the
use of HP systems and 7 clinical trials that demonstrate a reduction in
HAIs with UV.3,126 However, 11 of these studies used a before-after
design that is more likely subject to bias than cross-over studies or
randomized clinical trials. Two studies used a stronger epidemiologic
design, either a prospective cohort131 or randomized clinical trial.105
Specifically, the later study was a prospective, multicenter, cluster-
randomized, crossover trial in 9 hospitals that evaluated 3 strategies
for enhanced room disinfection (ie, Quat plus UV-C; bleach alone, and
bleach plus UV-C) compared to the standard strategy (ie, Quat). The
study showed that enhanced room decontamination strategies (ie,
bleach and/or UV-C decontamination) decreased the clinical inci-
dence of acquisition of target multidrug resistant organisms (ie,
MRSA, VRE, C difficile) by »10%-30% (P = .036). Comparing the best
strategy with the worst strategy (ie, Quat vs Quat/UV) revealed that a
reduction of 94% in epidemiologically important pathogens (ie,
60.8 vs 3.4) led to a 35% decrease in colonization/infection (2.3% vs
1.5%).144 These data demonstrated that a decrease in room contami-
nation was associated with a decrease in patient colonization/infec-
tion. To our knowledge, this is the first study that quantitatively
described the entire pathway whereby improved disinfection
decreases microbial contamination that in-turn reduced patient colo-
nization/infection.105,144
Based on these data, hospitals should use a “no touch” device for
terminal room decontamination after discharge of patients on contact
precautions. However, the multitude of commercially available devi-
ces makes choosing a device difficult. UV devices may vary because of
differences in UV wavelength, dose, ability to measure dose, and cost.
Similarly, HP devices may differ regarding concentration, method of
injecting HP into the room, dissemination of the HP in the room, and
cost. For these reasons, IPs should review the peer-reviewed litera-
ture and choose for purchase only devices with demonstrated bacte-
ricidal capability as assessed by carrier test method and/or ability to
disinfect actual rooms. Ideally, one should choose only “no touch”
devices that have demonstrated the ability to reduce HAIs.3,126
Continuous Room Decontamination
Even after cleaning and disinfection surfaces can rapidly become
recontaminated. Thus, hands of health care providers can become colo-
nized by touching contaminated environmental surfaces and patient
care equipment and then, via inadequate hand hygiene or inappropriate
glove use, can transfer health care pathogens from health care provider-
to-patient. Considering that routine cleaning of room surfaces by ES is
frequently inadequate, continuous room decontamination methods are
being evaluated. The intent of this technology is tomake surfaces hygien-
ically clean (not sterile), that is free of pathogens in sufficient numbers to
prevent human disease. These include: visible light disinfection (high-
intensity narrow-spectrum light);145,146 low concentrationHP; persistent
disinfectants;147−150 and self-disinfection surfaces (eg, copper).151 These
methods are under active investigation but, to date, have not been
assessed for their ability to reduce HAIs.151
SUMMARY
A bundle requires all elements to be evidence-based and imple-
mented uniformly and completely. The steps are simple and common
sense and include: creating policies and procedures; selection of
cleaning and disinfecting products; educating staff to include ES,
patient equipment, and nursing; monitoring compliance and feed-
back; implement “no touch” room decontamination technology; and
ensure compliance for patients on contact and enteric precautions.
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